• No results found

PD-L1 is highly expressed in Enzalutamide resistant prostate cancer

N/A
N/A
Protected

Academic year: 2020

Share "PD-L1 is highly expressed in Enzalutamide resistant prostate cancer"

Copied!
9
0
0

Loading.... (view fulltext now)

Full text

Loading

Figure

Figure 1: Progression on ENZ in CRPC patients is associated with increased frequency of PD-L1/2+ DCs in circulation
Figure 2: Differential expression of T cell checkpoint molecules in ENZ resistance. (A) Expression profile of checkpoint fluorescence intensity (MFI) on ENZR 42D and 42F cell lines compared to CRPC (=1)
Figure 4: non-AR driven ENZR 42D and 42F xenografts decrease tumor infiltrating PD-L1/2+ DCs in vivo

References

Related documents

Compared with MCAO/R group, Apelin 13 treatments significantly increased the phosphorylation levels of AMPK and ACC, as well as phosphorylation of GSK-3 β at Ser-9.. These

Over 45 cars available to test drive including 18 fitted with adaptations FREE entry, FREE parking and a FREE tea or coffee in a fully accessible indoor venue Over 40 scooters and

experiences w/intersectionality influence their leadership practices? How do Black female school leaders describe their awareness of intersectionality as it relates to

An interesting comparison between results from searches for DM at colliders and indirect and direct detection experiments can be obtained by translating vector and axial-vector

While mob justice is not necessarily new form of violence in Madagascar, this deregulation is a key point of departure for us to better understand the connections between

“Released Claims” shall mean any and all claims, rights, demands, liabilities and causes of action of every nature and description, to the fullest extent that the law permits

This differentiation follows either by analogy to the chance-based approach applied in the standard LRS cases where a solicitor allows a client’s claim to become